Oracle Unveils Oracle® Health Sciences Cloud

OracleOracle announced that its portfolio of Oracle Health Sciences Cloud Applications will be powered by the next-generation Oracle® Health Sciences Cloud, a scalable and secure software-as-a-service delivery platform tailored for the specific requirements and regulations of the health sciences market.

The enhanced Oracle Health Sciences Cloud delivers life sciences and healthcare applications with unparalleled performance, scalability and security. It supports the increasingly networked environment for research, clinical development, and healthcare delivery wherein data must be effectively and securely managed across multiple organizations, including life sciences companies, contract research organizations (CROs), academic medical centers, and regulators and outsourcing vendors.

In conjunction with Oracle Health Sciences Cloud Applications, Oracle Health Sciences Cloud will help health sciences organizations further accelerate IT deployments, reduce resources required to maintain IT infrastructure and gain a more predictable IT spending pattern. Oracle Health Sciences Cloud is developed and rigorously tested for the specific security and privacy requirements of the health sciences industry. This HIPAA certified cloud provides full qualification and validation testing for each instance of the deployed application and is compliant with U.S. Food & Drug Administration (FDA) 21 CFR Part 11.

Oracle Health Sciences solutions currently available as a service on the Oracle Health Sciences Cloud include electronic data capture, electronic patient reported outcomes, study design, coding and dictionary management, trial randomization and drug supply management, research clinic automation, as well as safety management and will expand over time. The Oracle Health Sciences Cloud currently hosts over 3,800 application instances supporting hundreds of thousands of users and millions of transactions per day in more than 117 countries.

The new Oracle Health Sciences Cloud will take advantage of Oracle’s hardware and software, including Oracle Fusion Middleware, Oracle Exadata Database Machine, and Oracle’s Sun ZFS Storage Appliance.

"Delivering cloud applications that support the stringent regulatory environment and networked nature of clinical trials requires not only technical expertise, but significant industry expertise, as well," said Neil de Crescenzo, senior vice president and general manager, Oracle Health Sciences. "Oracle Health Sciences Cloud and our proven portfolio of Oracle Health Sciences Cloud Applications offer customers a formidable combination of scalability, data security, value, and confidence."

Related news articles:

About Oracle
Oracle is the world's most complete, open, and integrated business software and hardware systems company. For more information about Oracle, please visit http://www.oracle.com.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...